FDA OK's Allergan's Botox for Migraine Sufferers

"The FDA approved Allergan's (NYSE:AGN) Botox injections to prevent chronic migraine headaches in adult patients. Botox has been historically used for the removal of wrinkles on the skin.

Dr. Russell Katz, director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research, said, ""Chronic migraine is one of the most disabling forms of headache. Patients with chronic migraine experience a headache more than 14 days of the month. This condition can greatly affect family, work, and social life, so it is important to have a variety of effective treatment options available.""

Sanford Bernstein analysts estimate that as a migraine treatment, Botox could generate an additional $1 billion in sales.

Allergan (NYSE:AGN) has a potential upside of 7.8% based on a current price of $68.86 and an average consensus analyst price target of $74.25. SmarTrend is bullish on shares of Allergan and our subscribers were alerted to buy on September 27, 2010 at $66.26. The stock has risen 3.9% since the alert was issued."

Category:

News & Politics

Tags:

• Allergan
• AGN
• Botox
• Migraine
• Pharmaceutical
• FDA
• Approval
• Stock
• News
• Trading
• Market
• Analysis

[amarantha213]

My neurollogist has recommended Botox injections for my migraines. It was approved by my insurance. It will require a co-pay that's substantial. It will be worth it if it helps. Migraines have caused me to miss work and not be able to socialize with others among other things. I am praying that the Botox is an effective treatment. It has to be done about every 2months, though.